PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Rheumatology, University of British Columbia, Vancouver, BC, Canada.\', \'Department of Medicine, Division of Hematology, University of British Columbia, Vancouver, BC, Canada.\', \'Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada.\', \'Department of Pediatrics, Division of Allergy & Immunology, University of British Columbia, Vancouver, BC, Canada.\', \'Department of Medicine, Division of Infectious Diseases, University of British Columbia, Vancouver, BC, Canada.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/ejh.13593
?:hasPublicationType
?:journal
  • European journal of haematology
is ?:pmid of
?:pmid
?:pmid
  • 33523540
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.06
?:rankingScore_hIndex
  • 75
is ?:relation_isRelatedTo_publication of
?:title
  • Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33523540>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33523540>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all